Circulating Neutrophil Extracellular Traps and Neutrophil Activation Are Increased in Proportion to Disease Severity in Human Malaria.
Plasmodium
malaria
neutrophil activation
neutrophil extracellular traps
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
24 05 2019
24 05 2019
Historique:
received:
30
09
2018
accepted:
11
11
2018
pubmed:
20
11
2018
medline:
3
3
2020
entrez:
20
11
2018
Statut:
ppublish
Résumé
Neutrophil activation results in Plasmodium parasite killing in vitro, but neutrophil products including neutrophil extracellular traps (NETs) mediate host organ damage and may contribute to severe malaria. The role of NETs in the pathogenesis of severe malaria has not been examined. In Papua, Indonesia, we enrolled adults with symptomatic Plasmodium falciparum (n = 47 uncomplicated, n = 8 severe), Plasmodium vivax (n = 37), or Plasmodium malariae (n = 14) malaria; asymptomatic P falciparum (n = 19) or P vivax (n = 21) parasitemia; and healthy adults (n = 23) without parasitemia. Neutrophil activation and NETs were quantified by immunoassays and microscopy and correlated with parasite biomass and disease severity. In patients with symptomatic malaria, neutrophil activation and NET counts were increased in all 3 Plasmodium species. In falciparum malaria, neutrophil activation and NET counts positively correlated with parasite biomass (Spearman rho = 0.41, P = .005 and r2 = 0.26, P = .002, respectively) and were significantly increased in severe disease. In contrast, NETs were inversely associated with parasitemia in adults with asymptomatic P falciparum infection (r2 = 0.24, P = .031) but not asymptomatic P vivax infection. Although NETs may inhibit parasite growth in asymptomatic P falciparum infection, neutrophil activation and NET release may contribute to pathogenesis in severe falciparum malaria. Agents with potential to attenuate these processes should be evaluated.
Sections du résumé
BACKGROUND
Neutrophil activation results in Plasmodium parasite killing in vitro, but neutrophil products including neutrophil extracellular traps (NETs) mediate host organ damage and may contribute to severe malaria. The role of NETs in the pathogenesis of severe malaria has not been examined.
METHODS
In Papua, Indonesia, we enrolled adults with symptomatic Plasmodium falciparum (n = 47 uncomplicated, n = 8 severe), Plasmodium vivax (n = 37), or Plasmodium malariae (n = 14) malaria; asymptomatic P falciparum (n = 19) or P vivax (n = 21) parasitemia; and healthy adults (n = 23) without parasitemia. Neutrophil activation and NETs were quantified by immunoassays and microscopy and correlated with parasite biomass and disease severity.
RESULTS
In patients with symptomatic malaria, neutrophil activation and NET counts were increased in all 3 Plasmodium species. In falciparum malaria, neutrophil activation and NET counts positively correlated with parasite biomass (Spearman rho = 0.41, P = .005 and r2 = 0.26, P = .002, respectively) and were significantly increased in severe disease. In contrast, NETs were inversely associated with parasitemia in adults with asymptomatic P falciparum infection (r2 = 0.24, P = .031) but not asymptomatic P vivax infection.
CONCLUSIONS
Although NETs may inhibit parasite growth in asymptomatic P falciparum infection, neutrophil activation and NET release may contribute to pathogenesis in severe falciparum malaria. Agents with potential to attenuate these processes should be evaluated.
Identifiants
pubmed: 30452670
pii: 5191210
doi: 10.1093/infdis/jiy661
pmc: PMC6542661
mid: EMS83105
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1994-2004Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 099875
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200909
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200909/Z/16/Z
Pays : United Kingdom
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
Infect Immun. 2016 Dec 29;85(1):
pubmed: 27795354
PLoS Med. 2017 Aug 29;14(8):e1002379
pubmed: 28850568
Blood. 2011 Nov 3;118(18):4946-56
pubmed: 21911835
Br J Haematol. 1999 Aug;106(2):391-9
pubmed: 10460597
Br J Haematol. 1994 May;87(1):100-5
pubmed: 7947233
Front Immunol. 2017 Jul 28;8:874
pubmed: 28804484
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Nat Commun. 2016 May 06;7:11537
pubmed: 27151551
Adv Parasitol. 2012;80:151-201
pubmed: 23199488
Trends Mol Med. 2016 Jun;22(6):453-457
pubmed: 27161599
Br J Clin Pharmacol. 2015 Sep;80(3):389-402
pubmed: 25778676
PLoS Med. 2005 Aug;2(8):e204
pubmed: 16104831
Tissue Barriers. 2017 Jan 2;5(1):e1268667
pubmed: 28452684
Sci Transl Med. 2018 Jun 27;10(447):
pubmed: 29950443
Nat Med. 2011 Dec 18;18(1):120-7
pubmed: 22179318
Gastroenterology. 2015 Dec;149(7):1920-1931.e8
pubmed: 26302488
PLoS Med. 2013 Dec;10(12):e1001575; discussion e1001575
pubmed: 24358031
J Cell Biol. 2010 Nov 1;191(3):677-91
pubmed: 20974816
BMC Infect Dis. 2017 Apr 27;17(1):313
pubmed: 28449641
Malar J. 2008 Feb 29;7:41
pubmed: 18312656
Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):598-601
pubmed: 1287909
J Thromb Haemost. 2012 Jan;10(1):136-44
pubmed: 22044575
Parasite Immunol. 1988 Jan;10(1):47-58
pubmed: 3281102
PLoS Pathog. 2016 Dec 7;12(12):e1006054
pubmed: 27926944
Infect Immun. 1990 Mar;58(3):788-93
pubmed: 2407658
Infect Immun. 2005 Mar;73(3):1764-70
pubmed: 15731077
Acta Trop. 2003 Jul;87(2):279-85
pubmed: 12826303
PLoS One. 2016 Oct 27;11(10):e0165340
pubmed: 27788243
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17097-102
pubmed: 18957536
Am J Trop Med Hyg. 2009 Nov;81(5):758-62
pubmed: 19861606
Front Immunol. 2013 Jan 11;3:420
pubmed: 23335924
J Immunol. 2018 Jun 1;200(11):3801-3813
pubmed: 29686052
Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):200-4
pubmed: 7778149
PLoS Pathog. 2015 Jan 08;11(1):e1004558
pubmed: 25569250
Trop Med Int Health. 2014 Sep;19 Suppl 1:7-131
pubmed: 25214480
mBio. 2016 Feb 16;7(1):e01300-15
pubmed: 26884431
PLoS Negl Trop Dis. 2012;6(6):e1710
pubmed: 22745844
J Immunol. 2012 Dec 1;189(11):5336-46
pubmed: 23100518
Cell Rep. 2015 Dec 29;13(12):2829-2841
pubmed: 26711347
J Infect Dis. 2009 Nov 15;200(10):1522-9
pubmed: 19803726
Nat Med. 2007 Apr;13(4):463-9
pubmed: 17384648
Thromb Haemost. 1994 Sep;72(3):457-64
pubmed: 7855798
Nat Rev Immunol. 2011 Jul 25;11(8):519-31
pubmed: 21785456
Malar J. 2008 Aug 02;7:148
pubmed: 18673572
Eur J Immunol. 1994 Dec;24(12):3211-5
pubmed: 7805749
Clin Exp Immunol. 2000 Apr;120(1):125-33
pubmed: 10759773
Blood. 2018 Sep 20;132(12):1332-1344
pubmed: 30026183
Clin Infect Dis. 2012 Oct;55(8):e67-74
pubmed: 22772803
Blood. 2014 Jun 12;123(24):3818-27
pubmed: 24620350